about
Interventions for psychotic symptoms concomitant with epilepsyInterventions for psychotic symptoms concomitant with epilepsyInterventions for psychotic symptoms concomitant with epilepsyThe promise of new antiepileptic drugs.Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems.Vigabatrin: a novel therapy for seizure disorders.Non-vision adverse events with vigabatrin therapy.When is it inappropriate to prescribe psychotropic medication?Psychosis of epilepsy: a multifaceted neuropsychiatric disorder.The new antiepileptic drugsAnticonvulsant drugs in bipolar disorder.Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.Behavioural effects of the newer antiepileptic drugs: an update.Diagnosis and management of depression and psychosis in children and adolescents with epilepsy.Brain tumor-related epilepsy.Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.Alternating and postictal psychoses: review and a unifying hypothesisTreatment of refractory complex partial seizures: role of vigabatrin.GABAergic drugs in the treatment of epilepsy: modern or outmoded?Modulation of ion channels in clinical psychopharmacology: adults and younger people.Patients with brain tumor-related epilepsy.Psychosis and seizure disorder: challenges in diagnosis and treatment.Vigabatrin-associated reversible acute psychosis in a child.Vigabatrin induced Cell loss in the Cerebellar Cortex of Albino Rats.Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis.Does bromide cause conversion of epilepsy to psychosis?Pragmatic difficulties in children with autism associated with childhood epilepsy.
P2860
Q24187052-F7015347-D606-4A93-B826-4777C924EF0CQ24240743-7625BF5B-2F65-4D88-9B75-085515A1A231Q24245840-FD41C262-D224-4361-93B1-B1D4DA7223A6Q30674774-811EF2E5-9B17-413B-8F1E-A2DC78D825FBQ33591417-868FF026-49B7-433D-A96D-10EEE615A81CQ33814543-F0658818-7CB7-46DF-8BDC-8A5188E4F36BQ34068916-42B22F6F-80BF-4222-B905-4E65533E9867Q34570618-2F65A3C0-DFE0-4FE2-9421-73158DDEC630Q34677575-355513FD-56FF-4671-8034-5A168B1C1C3BQ34799823-788660E5-F66B-4AD9-AE4B-57F1CE226DC3Q35236134-D8AFD92F-0D1C-4CB6-B466-D7C80DDFF8B1Q35329906-6501A064-1EED-4A7C-9E2B-5DFAF1E33605Q35609738-EF8E4716-CF4A-4B92-9336-9B83C1A45E11Q35941091-46317E78-764F-4F2D-BEB8-4F48D8BF0CC7Q36067319-AB698E6F-05A1-4C15-83D6-7E0F13C6E4F7Q36074460-4E67687A-F099-4269-A811-BFD91267A989Q36751563-FBC5B41E-8DBB-4E6A-BA5F-6D64271AA83BQ37620193-3B1CE3C7-A943-4C04-ADDC-F575D91621D8Q37856281-115A7294-4AC5-48D7-88A0-AE8C46F60C6FQ37960095-1D142509-4077-4135-BA34-90FCDC30F377Q38005050-457D9F07-967D-441A-8AB1-71C949B8EF5DQ38252369-9DF47171-C16B-4B9C-9C9D-21F6D64D1CB8Q40952932-B3D03A3C-59F1-4CED-BB4D-8D2205B3736DQ41848872-2539FBE7-23D9-4565-8C25-117732D73A4EQ43959064-4E2C5225-6281-46EA-9AAD-6995334A65F2Q44811416-DE27D3DC-94A0-45B4-9B19-E9F9EF9915F3Q48832229-0BC883B8-1A9C-4917-A727-5F0B0385818DQ50302508-E83BC3EF-F312-41BA-B007-D44C9331B5B8
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Vigabatrin and psychosis
@ast
Vigabatrin and psychosis
@en
Vigabatrin and psychosis
@nl
type
label
Vigabatrin and psychosis
@ast
Vigabatrin and psychosis
@en
Vigabatrin and psychosis
@nl
prefLabel
Vigabatrin and psychosis
@ast
Vigabatrin and psychosis
@en
Vigabatrin and psychosis
@nl
P2093
P2860
P356
P1476
Vigabatrin and psychosis
@en
P2093
J W Sander
M R Trimble
S D Shorvon
P2860
P356
10.1136/JNNP.54.5.435
P407
P577
1991-05-01T00:00:00Z